T
Tewes Tralau
Researcher at Federal Institute for Risk Assessment
Publications - 63
Citations - 2147
Tewes Tralau is an academic researcher from Federal Institute for Risk Assessment. The author has contributed to research in topics: Comamonas testosteroni & Medicine. The author has an hindex of 21, co-authored 54 publications receiving 1688 citations. Previous affiliations of Tewes Tralau include University of Konstanz & University of Manchester.
Papers
More filters
Journal ArticleDOI
Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects Current knowledge assembled at an international workshop at BfR, Germany
Matthias Peiser,Tewes Tralau,J. Heidler,A.M. Api,J. H. E. Arts,D. A. Basketter,John S. C. English,Thomas L. Diepgen,Robert C. Fuhlbrigge,Anthony A. Gaspari,Jeanne D. Johansen,Ann-Therese Karlberg,Ian Kimber,Jean Pierre Lepoittevin,Manfred Liebsch,Howard I. Maibach,Stefan F. Martin,H. F. Merk,Thomas Platzek,Thomas Rustemeyer,Axel Schnuch,Rob J. Vandebriel,Ian R. White,Andreas Luch +23 more
TL;DR: Research highlights included: advances in understanding of immune responses to contact sensitisers, the importance of autoxidation or enzyme-mediated oxidation for the activation of chemicals, the mechanisms through which hapten-protein conjugates are formed and the development of novel in vitro strategies for the identification of skin-sensitising chemicals.
Journal ArticleDOI
Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing.
Uwe Marx,Tommy B. Andersson,Anthony Bahinski,Mario Beilmann,Sonja Beken,Flemming R. Cassee,Murat Cirit,Mardas Daneshian,Susan Fitzpatrick,Olivier Frey,Claudia Gaertner,Christoph Giese,Linda G. Griffith,Thomas Hartung,Minne B. Heringa,Julia Hoeng,Wim H. de Jong,Hajime Kojima,Jochen Kuehnl,Marcel Leist,Andreas Luch,Ilka Maschmeyer,D. A. Sakharov,Adriënne J.A.M. Sips,Thomas Steger-Hartmann,Danilo A. Tagle,Alexander G. Tonevitsky,Tewes Tralau,Sergej Tsyb,Anja van de Stolpe,Rob J. Vandebriel,Paul Vulto,Jufeng Wang,Joachim Wiest,Marleen Rodenburg,Adrian Roth +35 more
TL;DR: The status quo of microphysiological systems available today against industry needs is reviewed, and the broad variety of approaches with fit-for-purpose potential in the drug development cycle are assessed, and feasibility solutions to reach the next levels of human biology in vitro are proposed.
Journal ArticleDOI
A medical-toxicological view of tattooing
Peter Laux,Tewes Tralau,Jutta Tentschert,Annegret Blume,Sascha Al Dahouk,Wolfgang Bäumler,Eric Bernstein,Beatrice Bocca,Alessandro Alimonti,Helen Colebrook,Christa de Cuyper,Lars Dähne,Urs Hauri,Paul C. Howard,Paul P. Janssen,Linda M. Katz,Bruce Klitzman,Nicolas Kluger,Lars Krutak,Thomas Platzek,Victoria Scott-Lang,Jørgen Serup,Wera Teubner,Ines Schreiver,Elena Wilkniß,Andreas Luch +25 more
TL;DR: Concerns are the potential for phototoxicity, substance migration, and the possible metabolic conversion of tattoo ink ingredients into toxic substances, which apply to cleavage products that are formed during laser-assisted tattoo removal.
Journal ArticleDOI
Non-Animal Models of Epithelial Barriers (Skin, Intestine and Lung) in Research, Industrial Applications and Regulatory Toxicology
Sarah Gordon,Mardas Daneshian,Joke A. Bouwstra,Francesca Caloni,Samuel Constant,Donna E. Davies,Gudrun Dandekar,Carlos A. Guzmán,Eric Fabian,Eleonore Haltner,Thomas Hartung,Thomas Hartung,Nina Hasiwa,Patrick Hayden,Helena Kandarova,Sangeeta Khare,Harald F. Krug,Carsten Kneuer,Marcel Leist,Guoping Lian,Uwe Marx,Marco Metzger,Katharina Ott,Pilar Prieto,Michael S. Roberts,Erwin Ludo Roggen,Tewes Tralau,Claudia Catharina Maria Van Den Braak,Heike Walles,Claus-Michael Lehr +29 more
TL;DR: An international group of experts in the field of epithelial barriers was convened from academia, industry and regulatory bodies to present both the current state of the art of non-animal models of the skin, intestinal and pulmonary barriers and to discuss future directions for both the development of new models and the refinement of existing test methods.
Journal ArticleDOI
Applying 'omics technologies in chemicals risk assessment:: Report of an ECETOC workshop
Roland Buesen,Brian N. Chorley,Beatriz Silva Lima,George P. Daston,Lize Deferme,Timothy M. D. Ebbels,Timothy W. Gant,Amber K. Goetz,John M. Greally,Laura Gribaldo,Jörg Hackermüller,Bruno Hubesch,Danyel Jennen,Kamin J. Johnson,Jun Kanno,Hans-Martin Kauffmann,Madeleine Laffont,Patrick D. McMullen,Richard R. Meehan,Mark Pemberton,Stefania Perdichizzi,Aldert H. Piersma,Ursula G. Sauer,Kerstin Schmidt,Hervé Seitz,Kayo Sumida,Knut Erik Tollefsen,Weida Tong,Tewes Tralau,Ben van Ravenzwaay,Ralf J. M. Weber,Andrew Worth,Carole L. Yauk,Alan Poole +33 more
TL;DR: It was considered promising to strive to link gene expression changes and pathway perturbations to the phenotype by mapping them to specific adverse outcome pathways, and the ECETOC workshop provided important incentives towards achieving this goal.